Verinata Sues Sequenom over Patent Rights | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Prenatal diagnostics testing technology firm Verinata Health today filed a lawsuit against Sequenom asking a federal court to find that its cell-free DNA sequencing methods used in its tests do not infringe on a Sequenom patent.

The company also claims Sequenom and its subsidiary, the Sequenom Center for Molecular Medicine infringes on its patent rights.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.